Kaleido, a miniature, patch-style insulin pump, is currently available in Germany, the Netherlands and France.
Once a healthcare provider has prescribed Kaleido and the prescription has been approved, users can move very quickly to receive their pump. The Utrecht, the Netherlands-based company says a distributor will coordinate training and arrange delivery of its Kaleido Starter Kit and consumables. According to the company, this provides users with the support and guidance they need.
Kaleido, described by the company as the smallest, lightest and most precise insulin patch pump in its class, offers premium materials and customizable aluminum shells in 10 color options to deliver the feel of personal technology rather than a traditional medical device. It integrates with Diabeloop’s self-learning automated insulin delivery algorithm and Dexcom’s leading continuous glucose monitors (CGMs).
Currently, Kaleido has availability with Diabeloop’s DBLG1 algorithm and Dexcom G6. It recently quelled concerns over Dexcom’s decision to cease production of G6 and move all lines to its next-generation G7.
ViCentra said beginning with Kaleido, DBLG1 and Dexcom G6 provides the fastest path to Kaleido with DBLG2 and Dexcom G7, when the next-generation pump with the newer algorithm and CGM are available. CEO Tom Arnold explained the company’s plans for a big commercial push with a next-generation pump on the way in an interview with Drug Delivery Business News last year.
“Kaleido is the smallest and lightest insulin patch pump in its class, designed to deliver insulin with high precision while fitting seamlessly into everyday life,” ViCentra said. “Now, access to Kaleido is faster and more straightforward than ever.”
